Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Sanofi, Dupixent and Regeneron
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.
Regeneron, Sanofi's Dupixent Get FDA Approval For Chronic Obstructive Pulmonary Disease Treatment
Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNY), Friday announced that the U.S. Food and Drug Administration has approved
Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent
Regeneron stock XX on XX after the company won FDA approval for Dupixent in chronic obstructive pulmonary disease, or COPD.
1d
Regeneron: Long-Term Defensive Investment
Regeneron's R&D expenses are projected to reach $5 billion, but the business remains highly profitable. Read why I rate REGN ...
2d
Sanofi blockbuster drug wins clearance in US for lung disease
Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Helene death toll rises
Illegal cloning sentencing
NYC tunnel shutdown
Harris' Las Vegas rally
Grammy-winning singer dies
Trump's Erie rally
Blocks songs from artists
Crew-9 astronauts at ISS
Oil prices climb
Three PFLP leaders killed
Actor John Ashton dies
Firefighters injured in crash
Defensive Player of the Year
$567M Taiwan defense aid
Line Fire prompts evacuation
Newsom vetoes AI safety bill
US wins Presidents Cup
37 militants killed in Syria
‘Wild Robot' tops box office
'Days of Our Lives' star dies
Hospitalized for burns
NC small plane crash
Temporary outage fixed
Ga. chemical plant fire
Condemns Israeli strikes
Ukrainian drones shot down
'SNL' launches 50th season
Steward CEO to step down
Faces fine to end Brazil ban
Chief adviser subpoenaed
Feedback